Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Updates add new study contacts and their details (Pere Barba, MD; Federica Cattaneo; Glen Lew as Study Director) and remove older contact Claire Fabre, while indicating site recruitment progression with 'Completed' statuses across locations.
    Difference
    0.7%
    Check dated 2026-05-23T22:36:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record's revision label was updated from v3.5.3 to v3.5.4, indicating a newer version of the document.
    Difference
    0.0%
    Check dated 2026-05-16T20:06:28.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page footer revision number was updated from v3.5.2 to v3.5.3, indicating an updated site/version display without changing the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-25T06:18:32.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:54:21.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T07:17:10.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No changes to core content or functionality.
    Difference
    0.0%
    Check dated 2026-03-05T19:39:44.000Z thumbnail image

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.